BWCS
IDXX icon

Beirne Wealth Consulting Services’s Idexx Laboratories IDXX Stock Holding History

Beirne Wealth Consulting Services’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-349
Closed -$223K – 165
2025
Q3 		$223K Buy
+349
New +$212K 0.05% 204
2021
Q1 		– Sell
-571
Closed -$285K – 135
2020
Q4 		$285K Sell
571
-48
-8% -$21.5K 0.14% 111
2020
Q3 		$243K Buy
+619
New +$229K 0.14% 116

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JSC
J. Stern & Co London, United Kingdom $1.03B AUM 20.71% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Beirne Wealth Consulting Services's IDXX Position: Q4 2025 in Review

Beirne Wealth Consulting Services sold out of Idexx Laboratories (IDXX) in Q4 2025, closing a stake of 349 shares — an estimated $223K sold.

Beirne Wealth Consulting Services first reported a position in IDXX in Q3 2020 and held it in 3 quarters. The position peaked at $285K in Q4 2020. 1,386 funds tracked by Wall St. Rank hold IDXX as of Q4 2025.

  • Beirne Wealth Consulting Services reported no remaining Idexx Laboratories position as of Q4 2025 after selling out during the quarter.
  • Beirne Wealth Consulting Services sold 349 Idexx Laboratories shares in Q4 2025, an estimated $223K.
  • Beirne Wealth Consulting Services first reported a position in Idexx Laboratories in Q3 2020 and held it in 3 quarters.
  • Beirne Wealth Consulting Services's Idexx Laboratories position peaked at $285K in Q4 2020.
  • 1,386 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2025.

Based on Beirne Wealth Consulting Services's 13F filing for Q4 2025, filed 29 Jan 2026.